Bristol Myers Squibb shares outperformed the market on Thursday following its second-quarter earnings report. The pharmaceutical giant delivered results that convincingly beat analyst estimates.
Bristol Myers Squibb Stock Rises After Q2 Earnings Beat Estimates
pharmaceuticalsearningsstock performanceQ2 results

